Cited by 1,163Lipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismParaoxonase enzyme and polymorphisms

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

Open access

Stampfer, Meir J., Sacks, Frank M., Salvini, Simonetta, Willett, Walter C., Hennekens, Charles H.·1991·New England Journal of Medicine

DOI 10.1056/nejm199108083250601

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The independent contributions of subfractions of high-density lipoprotein (HDL) cholesterol (HDL2 and HDL3) and apolipoproteins in predicting the risk of myocardial infarction are unclear. Prospective data are sparse, but HDL2 is widely believed to be a more important predictor than HDL3. METHODS: Blood samples were collected at base line from 14,916 men (ages, 40 to 84 years) who were participants in the Physicians' Health Study. After five years of follow-up, plasma samples from 246 men with new myocardial infarction (case subjects) were analyzed together with specimens from 246 men matched to them for age and smoking status who had not had a myocardial infarction. RESULTS: The levels of total cholesterol and apolipoprotein B-100 were significantly associated with an increased risk of myocardial infarction (data on levels of low-density lipoprotein cholesterol were unavailable). Both HDL cholesterol and HDL2 levels were associated with a substantially decreased risk of myocardial infarction, but the HDL3 level was the strongest predictor; the relative risk was 0.3 (95 percent confidence interval, 0.2 to 0.6) for those in the fifth of the group with the highest HDL3 levels, as compared with the fifth with the lowest levels. The benefit of a higher HDL cholesterol level was most pronounced among those with lower total cholesterol levels. Levels of apolipoprotein A-I and apolipoprotein A-II were also associated with decreased risk. However, the levels of HDL subfractions and apolipoproteins did not add significantly to the value of a multivariate model that included the ratio of total to HDL cholesterol in predicting myocardial infarction, whereas that ratio remained a significant independent predictor of risk. After adjustment for other risk factors, a change of one unit in the ratio of total to HDL cholesterol was associated with a 53 percent change in risk (95 percent confidence interval, 26 percent to 85 percent). CONCLUSIONS: This study underscores the importance of HDL cholesterol in predicting the risk of myocardial infarction and demonstrates protective effects of both the HDL3 and HDL2 subfractions of HDL cholesterol. We found little or no predictive value for the levels of apolipoproteins A-I, A-II, and B or HDL subfractions after conventional risk factors and the ratio of total to HDL cholesterol were considered.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199108083250601

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

From the New York Times Magazine
Minsky, & Hyman, P. (1979) · Cited by 6,899
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,267
THE TROMSØHEART-STUDY
Miller, N. E., Thelle, D. S., Førde, O. H., & Mjøs, O. D. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92274-7 · Cited by 1,206
Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure
Gidez, L. I., Miller, G. J., Burstein, M., Slagle, S., & Eder, H. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38059-7 · Cited by 757
Ischemic Heart Disease, Atherosclerosis, and Longevity
Gofman, J. W., Young, W., & Tandy, R. K. (1966) · Circulation · doi:10.1161/01.cir.34.4.679 · Cited by 587
Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery Disease
Maciejko, J. J., Holmes, D. R., Kottke, B. A., Zinsmeister, A. R., Dinh, D. M., & Mao, S. J. T. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090701 · Cited by 537
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel
Goodman, D. S., Hulley, S. B., Clark, L. T., Davis, C. E., Fuster, V., LaRosa, J. C., Oberman, A., Schaefer, E. J., Steinberg, D., Brown, W. V., et al. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.1.36 · Cited by 529
ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS?
Avogaro, P., Bon, G. B., Avogaro, P., Cazzolato, G., & Quinci, G. B. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91375-8 · Cited by 523

Show all 56 references

Research works printed but not linked: 10

Enger, 1979, Artery, 5, 170
Bennett, 1988, New York Times Magazine, 55
Jones PH, Gotto AM Jr. Assessment of lipid abnormalities. In: Hurst JW, Schlant RC, Rachley CE, Sonnenblick EH, Wenger NK, eds. The heart: arteries and veins. 7th ed. New York: McGraw-Hill, 1990:378–84.
10.1001/archinte.150.8.1645 · DOI
Musliner, 1988, Clin Chem, 34, B78
Hennekens, 1987, Circulation, 76, IV-501
Kempen, 1987, J Lab Clin Med, 109, 19
Avogaro P, Cazzolato G, Bittolo Bon G, Rorai E, Pontoglio E. Lipoprotein derangements in human atherosclerosis. In: Noseda G, Fragiacomo C, Fumagalli R, Paoletti R, eds. Lipoproteins and coronary atherosclerosis. Amsterdam: Elsevier, 1982:123–42.
Kladetzky, 1980, Artery, 7, 191
Desager JP, Rousseau M, Riesen WF, Harvengt C. Limitations of the predictive value for coronary vascular disease of plasma lipids and apoproteins AI, AII, B levels as measured before coronarography in 317 patients. In: de Gennes JL, Polonovski J, Paoletti R, eds. Latent dyslipoproteinemias and atherosclerosis. New York: Raven Press, 1984:165–74.

Sorted by citations

Items 701–800 of 999

Overcoming the Bitter Taste of Oils Enriched in Fatty Acids to Obtain Their Effects on the Heart in Health and Disease
Stamenković, A., Ganguly, R., Aliani, M., Ravandi, A., & Pierce, G. N. (2019) · Nutrients · doi:10.3390/nu11051179 · Cited by 14
Plasma Apolipoprotein B Levels Predict Platelet-Dependent Thrombosis in Patients with Coronary Artery Disease
Shechter, M., Merz, C. N. B., Paul-Labrador, M. J., Shah, P. K., & Kaul, S. (1999) · Cardiology · doi:10.1159/000006964 · Cited by 14
Breast Cancer Risk Factors in Two Distinct Ethnic Groups: Indian and Pakistani vs. American Premenopausal Women
Kamath, S. K., Murillo, G., Chatterton, R. T., Hussain, E. A., Amin, D., Mortillaro, E., Peterson, C. T., & Alekel, D. L. (1999) · Nutrition and Cancer · doi:10.1207/s1532791416-26 · Cited by 14
THE RELATION OF DOCUMENTED CORONARY ARTERY DISEASE TO LEVELS OF TOTAL CHOLESTEROL AND HIGH-DENSITY LIPOPROTEIN CHOLESTEROL
Freedman, D. S., Croft, J. B., Anderson, A. J., Byers, T., Jacobsen, S. J., Gruchow, H. W., Walker, J. A., & Barboriak, J. J. (1994) · Epidemiology · doi:10.1097/00001648-199401000-00012 · Cited by 14
Study of the Use of Lipid Panels as a Marker of Insulin Resistance to Determine Cardiovascular Risk
Bertsch, R. A., & Merchant, M. A. (2015) · The Permanente Journal · doi:10.7812/tpp/14-237 · Cited by 13
Association of myocardial infarction and angina pectoris with obesity and biochemical indices in the South Korean population
Chi, J. H., & Lee, B. J. (2022) · Scientific Reports · doi:10.1038/s41598-022-17961-y · Cited by 13
Apolipoprotein A-1 predicts coronary heart disease only at low concentrations of high-density lipoprotein cholesterol: an epidemiological study of Japanese-Americans
Sharp, D. S., Burchfiel, C. M., Rodríguez, B. L., Sharrett, A. R., Sorlie, P. D., & Marcovina, S. M. (2000) · International Journal of Clinical & Laboratory Research · doi:10.1007/s005990070032 · Cited by 13
Gender Alters the High-density Lipoprotein Cholesterol Response to Cardiac Rehabilitation
Savage, P. D., Brochu, M., & Ades, P. A. (2004) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200407000-00007 · Cited by 13
The M235T single nucleotide polymorphism in the angiotensinogen gene is associated with coronary artery calcium in patients with a family history of coronary artery disease
Joshi, P. H., Xu, H., LeStrange, R., Flockhart, N., Kirkland, B. L., Vazquez, G., Qian, Z., Sharma, A., Marvasty, I. B., Bhatt, K., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.10.039 · Cited by 13
HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease
Kuchta, A., Strzelecki, A., Ćwiklińska, A., Gruchała, M., Zdrojewski, Z., Kortas‐Stempak, B., Wieczorek, E., Gliwińska, A., Dąbkowski, K., & Jankowski, M. (2016) · Journal of Cardiology · doi:10.1016/j.jjcc.2016.04.007 · Cited by 14
A preclinical antihyperlipidemic evaluation of Artemisia vulgaris root in diet induced hyperlipidemic animal model
Kayamkani, A. K. (2015) · International Journal of Pharmacological Research · doi:10.7439/ijpr.v5i4.1885 · Cited by 13
The fact and fiction of lowering cholesterol in the primary prevention of coronary heart disease
Castelli, W. P. (1993) · Heart · doi:10.1136/hrt.69.1_suppl.s70 · Cited by 13
To what extent are the effects of diet on coronary heart disease lipid-mediated?
Serrano-Martínez, M., Martínez-Losa, E., Prado-Santamaría, M., Brugarolas‐Brufau, C., Fernandez‐Jarne, E., & Martínez‐González, M. Á. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.03.001 · Cited by 13
Effect of Thiazolidinediones on High-Density Lipoprotein Subfractions
Ovalle, F., & Bell, D. S. H. (2002) · Endocrine Practice · doi:10.4158/ep.8.2.102 · Cited by 13
The Efficacy of Lovastatin in Lowering Cholesterol in African Americans with Primary Hypercholesterolemia
Fong, R. L., & Ward, H. J. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00091-0 · Cited by 13
High-Density Lipoproteins and Coronary Heart Disease
Barter, P. J., & Rye, K.-A. (1994) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679400100306 · Cited by 13
Cardiovascular complications following renal transplantation
Sells, R. A. (1997) · Transplantation Reviews · doi:10.1016/s0955-470x(97)80012-2 · Cited by 13
Do simple prudent health behaviours protect men from myocardial infarction?
Spencer, C. A., Jamrozik, K. D., & Lambert, L. C. (1999) · International Journal of Epidemiology · doi:10.1093/ije/28.5.846 · Cited by 13
Cashew nut (Anacardium occidentale L.) and cashew nut oil reduce cardiovascular risk factors in adults on weight-loss treatment: a randomized controlled three-arm trial (Brazilian Nuts Study)
Meneguelli, T. S., Kravchychyn, A. C. P., Wendling, A. L., Dionísio, A., Bressan, J., Martino, H., Tako, E., & Hermsdorff, H. H. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1407028 · Cited by 10
HDL: To Treat or Not To Treat?
Pirillo, A., Tibolla, G., Norata, G. D., & Catapano, A. L. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0429-x · Cited by 12
Dyslipidaemia in hypertensive obese type 2 diabetic patients in Jamaica
Gordon, L., Ragoobirsingh, D., Morrison, E., McGrowder, D. A., Choo-Kang, E. G., & Martorell, E. (2010) · Archives of Medical Science · doi:10.5114/aoms.2010.17084 · Cited by 12
Relationship between breast arterial calcification and lipid profile, plasma atherogenic index, Castelli's risk index and atherogenic coefficient in premenopausal women
Yıldız, A., Seçen, Ö., Yıldız, C., & Çiçekçi, M. (2016) · IJC Metabolic & Endocrine · doi:10.1016/j.ijcme.2016.05.003 · Cited by 12
Association of High-Density Lipoprotein Subclasses with Carotid Intima-Media Thickness: Shimane CoHRE Study
Notsu, Y., Yano, S., Takeda, M., Yamasaki, M., Isomura, M., Nabika, T., & Nagai, A. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.38844 · Cited by 12
Unraveling the Complexity of HDL Remodeling: On the Hunt to Restore HDL Quality
Schoch, L., Badimón, L., & Vilahur, G. (2021) · Biomedicines · doi:10.3390/biomedicines9070805 · Cited by 12
The ABCC6 Transporter as a Paradigm for Networking from an Orphan Disease to Complex Disorders
Vilder, E. Y. G. D., Hosen, M. J., & Vanakker, O. M. (2015) · BioMed Research International · doi:10.1155/2015/648569 · Cited by 12
Trans fatty acids in margarines marketed in Brazil: Content, labeling regulations and consumer information
Benincá, C., Zanoelo, É. F., Luz, L. F. D. L., & Spricigo, C. B. (2009) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.200800185 · Cited by 12
High-Density Lipoprotein and Mortality Before Age 90 in Male Physicians
Rahilly‐Tierney, C. R., Sesso, H. D., Gaziano, J. M., & Djoussé, L. (2012) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.111.963850 · Cited by 12
Clinical Significance of Abnormal Electrocardiographic Findings in Individuals Aging With Spinal Injury and Abnormal Lipid Profiles
Szlachcic, Y., Carrothers, L., Adkins, R. H., & Waters, R. L. (2007) · Journal of Spinal Cord Medicine · doi:10.1080/10790268.2007.11754580 · Cited by 12
Impacto de los factores de riesgo cardiovascular en la población extremeña: aportación de la cohorte HERMEX para una estrategia preventiva
Félix-Redondo, F. J., Lozano, L., Álvarez-Palacios, P., Grau, M., Ramírez-Moreno, J. M., & Fernandez-Berges, D. J. (2019) · Atención Primaria · doi:10.1016/j.aprim.2018.11.006 · Cited by 12
High fat diet altered cardiac metabolic gene profile in Psammomys obesus gerbils
Sahraoui, A., Dewachter, C., Vegh, G., Entee, K. M., Naeije, R., Bouguerra, S. A., & Dewachter, L. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01301-y · Cited by 13
LDL receptor mutations and ApoB mutations are not risk factors for ischemic cerebrovascular disease of the young, but lipids and lipoproteins are
Frikke‐Schmidt, R., Arlien-Søborg, P., Thorsen, S., Jensen, H. K., & Vorstrup, S. (1999) · European Journal of Neurology · doi:10.1046/j.1468-1331.1999.660691.x · Cited by 12
Changes in Lipid Profile Between Flare and Remission of Patients with Systemic Lupus Erythematosus: A Prospective Study
Urquizu-Padilla, M., Balada, E., Chacón, P. M., Hermosilla, E., Vilardell, M., & Ordi‐Ros, J. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.081097 · Cited by 12
The influence of duration of follow-up on the association between alcohol and cause-specific mortality in a prospective cohort study
Rod, N. H., Thygesen, L. C., Johansen, D., Jensen, G. B., & Grønbæk, M. (2004) · Annals of Epidemiology · doi:10.1016/j.annepidem.2004.04.002 · Cited by 12
Postprandial lipemia differentially influences high density lipoprotein subpopulations LpAI and LpAI,AII.
James, R. W., & Pometta, D. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41156-3 · Cited by 12
Hepatic lipase C-480T polymorphism modifies the effect of HDL cholesterol on the risk of acute myocardial infarction in men: a prospective population based study
Fan, Y., Salonen, J. T., Koivu, T. A., Tuomainen, T.-P., Nyyssönen, K., Lakka, T. A., Salonen, R., Seppänen, K., Nikkari, S. T., Tahvanainen, E., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.010652 · Cited by 12
Wine and mortality
Grønbæk, M. (1997) · BioFactors · doi:10.1002/biof.5520060402 · Cited by 11
Prevention of coronary heart disease Part I. Primary prevention
Liesbon, P. R., & Amsterdam, E. A. (1999) · Disease-a-Month · doi:10.1016/s0011-5029(99)90016-0 · Cited by 11
Risk factors for acute myocardial infarction in coastal region of india: A case-control study
Rao, V. V., Rao, P., & Carvalho, N. (2014) · Heart India · doi:10.4103/2321-449x.140229 · Cited by 11
Effect of gemfibrozil on the composition and oxidation properties of very-low-density lipoprotein and high-density lipoprotein in patients with hypertriglyceridemia
Hsu, H., Lee, Y., Yeh, H.-T., & Chen, M.-F. (2001) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2001.114991 · Cited by 10
Differential Regulation of ABCA1 and Macrophage Cholesterol Efflux by Elaidic and Oleic Acids
Shao, F., & Ford, D. A. (2013) · Lipids · doi:10.1007/s11745-013-3808-0 · Cited by 11
Selective screening for dyslipidemia in a Canadian population
Reeder, B. A., Liu, L., & Horlick, L. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00063-1 · Cited by 11
The association between apolipoprotein A‐1 plasma level and premature coronary artery disease: A systematic review and meta‐analysis
Aghajani, M. H., Neishaboori, A. M., Ahmadzadeh, K., Toloui, A., & Yousefifard, M. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14578 · Cited by 12
Do dietary phytochemicals with cytochrome P-450 enzyme-inducing activity increase high-density-lipoprotein concentrations in humans?
Nanjee, M. N., Verhagen, H., van Poppel, G., Rompelberg, C., van Bladeren, P., & Miller, N. (1996) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/64.5.706 · Cited by 11
Association Between Apolipoprotein E Gene Polymorphism and Myocardial Infarction
Tanguturi, P., Pullareddy, B., Kumar, P. S., & Murthy, D. K. (2013) · Biochemical Genetics · doi:10.1007/s10528-013-9572-2 · Cited by 11
Saturated fatty acid consumption: outlining the scale of the problem and assessing the solutions
Mason, P., Porter, S., Berry, S. E., Stillman, P., Steele, C., Kirby, A., Griffin, B. A., & Minihane, A. M. (2009) · Nutrition Bulletin · doi:10.1111/j.1467-3010.2008.01737.x · Cited by 11
Plant monoterpenes do not raise plasma high-density-lipoprotein concentrations in humans
Cooke, C. J., Nanjee, M. N., Dewey, P., Cooper, J. A., Miller, G. J., & Miller, N. E. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.5.1042 · Cited by 11
The effects of low density lipoprotein and high density lipoprotein on phosphoinositide hydrolysis in bovine aortic endothelial cells
Myers, D. E., Fidge, N., Stanton, H., & Larkins, R. G. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90004-z · Cited by 11
Once-daily, extended-release gemfibrozil in patients with dyslipidemia
Gotto, A. M., Breen, W. J., Corder, C. N., Dunn, J. K., Goldberg, A. C., Knopp, R. H., Schrott, H. G., & Sprecher, D. L. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90573-u · Cited by 11
Heart disease in the assessment and treatment of hypercholesterolemia: Coronary artery disease and other atherosclerotic disease, family history, and left ventricular hypertrophy
Gotto, A. M. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90226-7 · Cited by 11
Screening for Dyslipidemia:Practice Parameter
Hostetter, A. L. (1995) · American Journal of Clinical Pathology · doi:10.1093/ajcp/103.4.380 · Cited by 11
Does Continuous Ambulatory Peritoneal Dialysis Induce Hypercholesterolemia?
Panarello, G., Calianno, G., Baz, H. D., Signori, D., Cappelletti, P., & Tesio, F. (1993) · Peritoneal Dialysis International · doi:10.1177/089686089301302s106 · Cited by 11
Atherogenic indices in pseudoexfoliation syndrome
Mirza, E. (2019) · Eye · doi:10.1038/s41433-019-0506-z · Cited by 10
Potential Beneficial Effects of Tulbaghia violacea William Henry Harvey (Alliaceae) on Cardiovascular System - A Review
Raji, I., Obikeze, K., & Mugabo, P. (2015) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v14i6.25 · Cited by 10
Aumento do índice de massa corporal em relação a variáveis clínicas e laboratoriais quanto ao sexo em indivíduos sem evidências de cardiopatia
Araújo, F., Yamada, A. T., Markus, M. R. P., Antelmi, I., Latorre, M. D. R. D. D. O., & Mansur, A. J. (2007) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2007000600001 · Cited by 10
The consumption of 12 Eggs per week for 1 year does not alter fasting serum markers of cardiovascular disease in older adults with early macular degeneration
Aljohi, H., Dopler‐Nelson, M., Cifuentes, M., & Wilson, T. A. (2018) · Journal of Nutrition & Intermediary Metabolism · doi:10.1016/j.jnim.2018.11.004 · Cited by 10
Zinc Finger Protein 202, genetic variation, and HDL cholesterol in the general population
Stene, M. C. A., Frikke‐Schmidt, R., Nordestgaard, B. G., & Tybjærg‐Hansen, A. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500521-jlr200 · Cited by 9
Metformin Increases HDL3–Cholesterol and Decreases Subcutaneous Truncal Fat in Nondiabetic Patients with HIV-Associated Lipodystrophy
DIEHL, L. A., Fabris, B. A., Barbosa, D. S., de Faria, E. C., Wiechmann, S. L., & Carrilho, A. J. F. (2008) · AIDS Patient Care and STDs · doi:10.1089/apc.2008.0012 · Cited by 10
Type of Alcoholic Beverage and Cardiovascular Disease - Does it Matter?
Grønbæk, M. (2003) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182670301000102 · Cited by 18
Family history of myocardial infarction, stroke and diabetes and cardiometabolic markers in children
Berentzen, N. E., Wijga, A. H., van Rossem, L., Koppelman, G. H., van Nieuwenhuizen, B., Gehring, U., Spijkerman, A. M. W., & Smit, H. A. (2016) · Diabetologia · doi:10.1007/s00125-016-3988-2 · Cited by 10
Phytocompounds as Potential Agents to Treat Obesity-Cardiovascular Ailments
Meriga, B., Ganjayi, M. S., & Naidu, P. B. (2018) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/1871525715666170830131217 · Cited by 10
A Retinoic Acid β2-Receptor Agonist Exerts Cardioprotective Effects
Marino, A., Sakamoto, T., Tang, X., Gudas, L. J., & Levi, R. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.250605 · Cited by 10
Triglyceride to high density lipoprotein cholesterol ratio may serve as a useful predictor of major adverse coronary event in female revascularized ST-elevation myocardial infarction
Wan, G., Xia, W., Ji, L., Qin, H., & Zhang, Y. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.06.049 · Cited by 10
Reference Materials for the Standardization of the Apolipoproteins A-I and B, and Lipoprotein(a).
Dati, F., & Tate, J. R. (2001) · Europe PMC (PubMed Central) · Cited by 10
Plasma Triglyceride-Rich Lipoprotein and High Density Lipoproteins Disorders Associated with Atherosclerosis
Genest, J. J., & Cohn, J. S. (1998) · Journal of Investigative Medicine · doi:10.1177/170882679804600807 · Cited by 10
Pathophysiology of Atherosclerosis
Kumar, A. G., & Ballantyne, C. M. (1998) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-5715-9_1 · Cited by 10
Omega-3 Fatty Acids and Heart Disease
Nettleton, J. A. (1995) · Springer eBooks · doi:10.1007/978-1-4615-2071-9_3 · Cited by 10
Treating mixed dyslipidemias: Why and how
Ballantyne, C. M. (2001) · Clinical Cardiology · doi:10.1002/clc.4960240704 · Cited by 10
Apolipoproteins B and A-l as predictors of risk of coronary artery disease
Srinivasan, S. R., & Berenson, G. S. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07135-5 · Cited by 10
Apolipoprotein e4 allele and the risk of CAD death in type 2 diabetes mellitus with ischaemia electrocardiographic change
Xiang, G., Xiang-jiu, Y., Lin-shuang, Z., Zhi-song, C., & Yu-sheng, H. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.09.001 · Cited by 10
HDL steady state levels are not affected, but HDL apoA-I turnover is enhanced by Lifibrol in patients with hypercholesterolemia and mixed hyperlipidemia
Winkler, K. E., Schaefer, J. R., Klima, B., Nuber, C., Friedrich, I., Köster, W., Gierens, H., Scharnagl, H., Soufi, M., Wieland, H., et al. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00351-2 · Cited by 10
Targeting Cardiovascular Risk Associated with Both Low Density and High Density Lipoproteins Using Statin-niacin Combination Therapy
Duvall, W. L., Blazing, M. A., Saxena, S., & Guyton, J. R. (2002) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182670200900607 · Cited by 10
Apolipoprotein A-I Milano: sex-related differences in the concentration and composition of apoA-I- and apoB-containing lipoprotein particles.
Bekaert, E. D., Alaupovic, P., Knight‐Gibson, C., Franceschini, G., & Sirtori, C. R. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41325-2 · Cited by 10
THE EPIDEMIOLOGIC BASIS OF CORONARY DISEASE PREVENTION
Cunningham, S. L. (1992) · Nursing Clinics of North America · doi:10.1016/s0029-6465(22)02758-x · Cited by 10
The prevention paradox revisited
Hawks, D. (1992) · Drug and Alcohol Review · doi:10.1080/09595239200185741 · Cited by 10
Antihypertensives
Golomb, B. A., & Criqui, M. H. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.6.535 · Cited by 10
Significant changes in VLDL-Triacylglycerol and glucose tolerance in obese subjects following ten days of training
Angelopoulos, T. J., Lewis, R. R., Jamurtas, T., & Schumann, C. (1998) · European Journal of Applied Physiology · doi:10.1007/s004210050376 · Cited by 10
Lipid Parameters Including Lp(a) in Hemodialysis Patients
Elisaf, M., Bairaktari, H. T., Tzatlas, C., Germanos, N. P., Koulouridis, E., Pappas, M., Siamopoulos, K. C., & Tsolas, O. (1994) · Renal Failure · doi:10.3109/08860229409045081 · Cited by 10
Cost‐Effective Cholesterol Monitoring by Enzyme‐Based Electrochemical Assay
Ekşin, E., Senturk, H., & Erdem, A. (2024) · ChemistrySelect · doi:10.1002/slct.202304593 · Cited by 9
Association between Apolipoprotein B/Apolipoprotein A-1 and arterial stiffness in metabolic syndrome
Kim, M. K., Ahn, C. W., Kang, S., Ha, J. Y., Baek, H., Park, J. S., & Kim, K. R. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.07.005 · Cited by 9
Influence of strength, endurance and concurrent training on the lipid profile and blood testosterone and cortisol response in young male wrestlers
Mirghani, S. J., Agha-Alinejad, H., Azarbayjani, M. A., Mazidi, A., & Mirghani, S. A. (2014) · Baltic Journal of Health and Physical Activity · doi:10.2478/bjha-2014-0001 · Cited by 9
Focusing on High-Density Lipoprotein for Coronary Heart Disease Risk Reduction
Davidson, M. H. (2011) · Cardiology Clinics · doi:10.1016/j.ccl.2010.11.005 · Cited by 9
Effects of lecithin: Cholesterol acyltransferase genotypes, enzyme levels, and activity on high-density lipoprotein levels
Ağırbaşlı, D., Çırakoğlu, B., Eren, F., Sumerkan, M. C., Aksoy, Ş., Aral, C., & Ağırbaşlı, M. A. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.02.008 · Cited by 9
Comparison of Two Types of Diets on Losing Weight and Lipid Profile of Overweight/Obese Middle-Aged Women Under Exercise Condition
Rezaeipour, M. (2014) · Health Scope · doi:10.17795/jhealthscope-15611 · Cited by 9
Evaluation of dyslipidaemia in patients with rheumatoid arthritis in South Indian population
Vinapamula, K. S., Manohar, S. M., Bitla, A. R. R., Kanduri, R., Bhattaram, S. K., & Narasimha, S. R. P. V. L. (2013) · Indian Journal of Rheumatology · doi:10.1016/j.injr.2013.06.006 · Cited by 9
Fitness, Diet and Coronary Risk Factors in a Sample of Southeastern U.S. Children.
PERRY, A. C., Tremblay, L. M., Signorile, J. F., Kaplan, T. A., & Miller, P. C. (1997) · Applied Human Science Journal of Physiological Anthropology · doi:10.2114/jpa.16.133 · Cited by 9
Enfermedad cardiovascular y grasas: “amigo o villano”
Rubio, M. Á. (2002) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(02)74448-3 · Cited by 9
The Effects of Dietary Fatty Acids on Lipid Metabolism
Vemuri, M., & Kelley, D. S. (2007) · doi:10.1201/9781420006902-25 · Cited by 9
Poland and United States Collaborative Study on Cardiovascular Epidemiology
Broda, G., DAVIS, C. E., Pająk, A., Williams, O. D., Rywik, S. L., Bączyńska, E., Folsom, A. R., & Szklo, M. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.2.339 · Cited by 9
The Good, The Bad, and The Ugly in Diabetic Diets
Vinik, A. I., & Wing, R. R. (1992) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30217-2 · Cited by 9
Role of genetic factors (CETP gene Taq I B polymorphism and Apo A-I gene Msp I polymorphism) in serum HDL-C levels in women
Motohashi, Y., Maruyama, T., Murata, M., Nakano, S., Maruyama, C., Kyotani, S., Tsushima, M., & Saruta, T. (2004) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/s0939-4753(04)80041-3 · Cited by 9
Cholesterol lowering effect of SG-GN3, the extract of salted and fermented small shrimps, Acetes japonicus, in Triton WR-1339 or high cholesterol-diet induced hypercholesterolemic rats
Seok, S. H., Park, J., Cho, S.-A., Choi, S.-A., & Park, J.-H. (2004) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2003.12.032 · Cited by 9
UK food industry responses to the Health of the Nation White Paper
Richardson, D. (1995) · British Food Journal · doi:10.1108/00070709510082434 · Cited by 13
Alcohol's influence on plasma lipoproteins: A nonhuman primate model
Hojnacki, J. L. (1994) · Nutrition Research · doi:10.1016/s0271-5317(05)80250-7 · Cited by 8
Desirable serum total cholesterol with low HDL cholesterol levels. An undesirable situation in coronary heart disease.
Sacks, F. M. (1992) · Circulation · doi:10.1161/01.cir.86.4.1341 · Cited by 10
Self-citation
Plasma lipids and other cardiovascular risk factors in Costa Rican adolescents
Irwig, M. S., Siles, X., Gotto, A. M., Rifai, N., & Campos, H. (2000) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892000000900002 · Cited by 9
Segregation Analysis of HDL3-C Levels in Families of Patients Undergoing Coronary Arteriography at an Early Age
Coresh, J., Beaty, T. H., Prenger, V. L., Xu, J., & Kwiterovich, P. O. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.9.1307 · Cited by 9
Serum Apolipoprotein-A2 Levels Are a Strong Predictor of Future Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention
Akiyama, T., Ikegami, R., Kubota, N., Takano, T., Yoneyama, S., Okubo, T., Hoyano, M., Ozaki, K., & Inomata, T. (2024) · Circulation Journal · doi:10.1253/circj.cj-24-0242 · Cited by 8
Polydextrose in Lipid Metabolism
Putaala, H. (2013) · InTech eBooks · doi:10.5772/51791 · Cited by 10
Regulation of Cholesterol Transporters by Nuclear Receptors
Matsuo, M. (2023) · Receptors · doi:10.3390/receptors2040014 · Cited by 8
Associations between metabolic dysfunction-associated fatty liver disease and atherosclerotic cardiovascular disease
Wen, W., Fan, H., Zhang, S., Hu, S., Chen, C., Tang, J., You, Y., Wang, C., Li, J., Luo, L., et al. (2024) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2024.06.022 · Cited by 8

Authors: Stampfer, M. J., Sacks, F. M., Salvini, S., Willett, W. C., & Hennekens, C. H.
Affiliations: Brigham and Women's Hospital (US)
ORCID: Stampfer, Meir J.
Sacks, Frank M.
Willett, Walter C.
Hennekens, Charles H.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1991-08-08
Volume: 325
Issue: 6
Pages: 373-381
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199108083250601
OpenAlex: W2337032743
Cited by: 1,163
References: 56
Citations by year: 2026: 6 · 2025: 5 · 2024: 10 · 2023: 10 · 2022: 7 · 2021: 12 · 2020: 14 · 2019: 12 · 2018: 18 · 2017: 17 · 2016: 24 · 2015: 31 · 2014: 34 · 2013: 33 · 2012: 31
FWCI: 80.75
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (HL-34595, HL 26490, R01HL034595)
National Cancer Institute (R01CA042182, CA 42182)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords: myocardial infarction, HDL cholesterol, HDL2, HDL3, apolipoprotein B-100, apolipoprotein A-I, apolipoprotein A-II, TC/HDL-C ratio, cardiovascular risk prediction, total cholesterol, men, Physicians' Health Study, lipoprotein subfractions, risk factors, coronary heart disease prevention, statin therapy
MeSH terms: Adult, Aged, Aged, 80 and over, Apolipoproteins, Apolipoproteins A, Apolipoproteins B, Cholesterol, Humans, Cholesterol, HDL, Male, Middle Aged, Myocardial Infarction, Prospective Studies, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks